Form 4: Natera Executive Solomon Moshkevich Reports Charitable Stock Donations

Natera's President of Clinical Diagnostics, Solomon Moshkevich, reported donating shares of company stock to charity in two separate transactions.

Summary

• Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
• On December 19, 2024, Mr. Moshkevich donated 125 shares of Natera common stock to charity.
• On December 23, 2024, he donated an additional 81 shares of Natera common stock to charity.
• Both transactions were reported as gifts with a price of $0 per share.
• Following these transactions, Mr. Moshkevich's direct holdings of Natera common stock decreased from 114,787 to 114,706 shares.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no positive or negative implications for the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive and does not indicate any specific industry trends.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders across all publicly traded companies.
• The charitable donation of shares is a common practice among executives and is not unique to Natera or its industry.

Stakeholder Impact

• The stock donations have a minor impact on the total outstanding shares of Natera.
• The transactions do not have a material impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Beneficial Ownership, Natera, Stock Donation, Charitable Contribution, Solomon Moshkevich, NTRA, Executive Stock